华仁药业股份有限公司

The company was founded in May 1998. It is a modern medical and health industry group integrating R&D, production and sales, focusing on preparations, APIs, pharmaceutical packaging materials and medical devices. In August 2010, the company was successfully listed on the Shenzhen Stock Exchange. In July 2019, the company changed its shares, and the Xi'an Qujiang New Area Management Committee became the actual controller of the company. The company is a state-owned pharmaceutical and health industry group integrating R&D, production, and sales, with products such as narcology, respiratory medicine, nephrology, therapeutic high-capacity preparations, medical devices, etc., with basic infusions and health products as the two wings, and comprehensive collaborative development of raw materials, pharmaceuticals, pharmaceutical packaging, medical devices, etc. The company's main products: basic infusion, blood volume booster, blood purification, anti-infective, circulatory system, hemostasis, neurological, anti-hepatitis and hepatitis adjuvant products, peritoneal dialysis solution, low calcium peritoneal dialysis solution, doxophylline injection, compound potassium hydrogen phosphate injection, fasudil hydrochloride injection, diquinonium chloride tablets, caffeine citrate injection, levofloxacin injection, terbutaline sulfate injection, pentazocin injection, salbutamine sulfate injection, pentoxifylline injections, etc. Corporate honors: The company won the honorary title of “Civilized Enterprise”, “2018 Top Ten Enterprises” and “2018 Advanced Unit for Work Safety” in Rizhao High-tech Zone. It was awarded the 2018 Advanced Unit for Trade Union Work by the Laoshan District Federation of Trade Unions. The company won a series of honors such as “2018 China's Top 100 Chemical and Pharmaceutical Industry Enterprises Comprehensive Strength”, “2018 China's Chemical and Pharmaceutical Industry Integration Promotion Excellent Enterprise Brand”, “National Key Technological Transformation 'Double High and One Excellent” Project, “National AAA Credit Enterprise”, “Shandong Pharmaceutical Industry Outstanding Enterprise in the 60th Anniversary of the Founding of the Nation”, “Shandong Quality Management Award”, and “China's Top 100 Chemical and Pharmaceutical Industry Enterprises with Comprehensive Strength”.